ClinicalTrials.gg
RecruitingNCT07943611Updated Nov 17, 2026

Laparoscopic Fundoplication With or Without Fixation to the Diaphragm for Gastroesophageal Reflux Disease or Hiatal Hernia

An interventional study of During laparoscopic fundoplication, one group secures the esophagus to the diaphragm. in Gastroesophageal Reflux Disease, sponsored by Nanchong Central Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Nanchong Central Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jan 2025, registered Sep 2026).
  • Started Jan 2025; still recruiting 1 year 10 months later.
Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 56 studies in Gastroesophageal Reflux with a site in China — 16 open to participants now, 17 under way, none of them phase 3. Gastroesophageal Reflux · China.

Planned enrollment
5th of 39
240 · median 90
Started
2025
with 4 others
No phase
24 of 56
11 open now
Primary completion
2027-06
later than 9 of 16 live
Registered
55th of 56
by date
Lead sponsor
2 of 56
Nanchong Central Hospital

Among the 56 studies in Gastroesophageal Reflux with a site in China, this one is the 5th largest by planned enrollment of the 39 interventional ones that give a count, is one of 5 that started in 2025, is one of 24 with no phase, reaches primary completion later than 9 of the 16 other live ones, and was the 55th registered.

Gastroesophageal Reflux

1,215 studies on the registry are indexed under Gastroesophageal Reflux; 203 are open to participants now.

Browse Gastroesophageal Reflux studies →

Open to participants now

16 of the 56 studies in Gastroesophageal Reflux with a site in China are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 133 Gastroesophageal Reflux studies recruiting now, 57 (43%) set no upper age limit and 53 (40%) stop at 75 or younger; 22 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 56 studies in Gastroesophageal Reflux with a site in China, or all of them as a file.
02

Study summary

To compare the clinical efficacy of fixation to diaphragm or not during fundoplication in patients with GERD, and to provide high-level evidence for clinical surgical decision-making.

Enrolled patients were were randomly divided into two groups, one fixed to the diaphragm or the other not fixed to the diaphragm during laparoscopic fundoplication.

The primary outcome was recurrence of GERD, assessed by endoscopy and/or 24-hour pH monitoring at 6 and 12 months after surgery. Reoperation for recurrent GERD or hiatal hernia was also recorded.

03

Conditions studied

  • Gastroesophageal Reflux Disease
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age: Patients over 18 years old.
  • Diagnosed with gastroesophageal reflux disease (GERD) (confirmed by endoscopy or 24-hour pH monitoring).
  • Agree to participate in this study and sign the form.

Exclusion criteria

Exclusion Criteria:

  • Combined with serious heart, liver, kidney and other diseases.
  • Pregnant or lactating women.
  • Patients with to surgery.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
240 participants (estimated)

Study arms

  • Experimental
    Fixed to the Diaphragm

    Procedure: During laparoscopic fundoplication, one group secures the esophagus to the diaphragm.

  • No intervention
    Not Fixed to the Diaphragm

Interventions

  • ProcedureDuring laparoscopic fundoplication, one group secures the esophagus to the diaphragm.

    During laparoscopic fundoplication, one group secures the esophagus to the diaphragm.

06

What researchers measure

Primary outcomes

  1. The primary outcome was recurrence of GERD, assessed by endoscopy and/or 24-hour pH monitoring, and reoperation for recurrent GERD or hiatal hernia was also recorded.

    Time frame: At12 months after surgery

Secondary outcomes

  1. Secondary outcomes included postoperative complications, including reflux symptoms, abdominal pain, indigestion, and dysphagia, GERD-HRQL assessed symptom severity and QoL improvement pre-treatment vs. post-treatment at 6 and 12 months post-surgery.

    Time frame: At 12 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Beijing Anzhen Nanchong Hospital of Capital Medical University and Nanchong Central Hospital
    Nanchong, Sichuan 637000, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Jun 2027, 29 months after the start.

Of 193 non-industry interventional studies with no phase under Gastroesophageal Reflux, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 68. This study's planned 29 months is close to that.

Counting every sponsor, half of 227 studies reached it within 31 months; a quarter within 12 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 3, 2026
First posted
Nov 17, 2026
StartActual
Jan 3, 2025
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943611
Lead sponsor
Nanchong Central Hospital
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Jan 3, 2025
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Yunhong Tian, PhD
Contact
drtianyunhong@126.com
13508087719

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion